Equine PLGF-1 antibody and antigen (recombinant protein)

Diagnostic anti-Equine PLGF-1 antibodies pairs and antigen for animal health (animal Equine/Horse angiogenesis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-PLGF-1-Ag01Equine PLGF-1$3090.00
GMP-EQU-PLGF-1-Ab01Anti-Equine PLGF-1 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-PLGF-1-Ab02Anti-Equine PLGF-1 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-PLGF-1-Ab03Anti-Equine PLGF-1 human monoclonal antibody (mAb)$3090.00
GMP-EQU-PLGF-1-Ab04Anti-Equine PLGF-1 human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-PLGF-1-Ag01
Product NameEquine PLGF-1
Target/BiomarkerEquine PLGF-1
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine PLGF-1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PLGF-1 level test of animal Equine/Horse with angiogenesis.
TagHis
Reconized/Reactive SpecicsEquine PLGF-1
Product descriptionRecombinant Equine PLGF-1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-PLGF-1-Ab01,GMP-EQU-PLGF-1-Ab02
Target/BiomarkerEquine PLGF-1
Product NameAnti-Equine PLGF-1 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine PLGF-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PLGF-1 antibodies in Equine PLGF-1 level test of animal Equine/Horse with angiogenesis.
Product descriptionAnti-Equine PLGF-1 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PLGF-1 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-PLGF-1-Ab03,GMP-EQU-PLGF-1-Ab04
Target/BiomarkerEquine PLGF-1
Product NameAnti-Equine PLGF-1 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine PLGF-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PLGF-1 antibodies in Equine PLGF-1 level test of animal Equine/Horse with angiogenesis.
Product descriptionAnti-Equine PLGF-1 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine Placental Growth Factor-1 (ePLGF-1) stands as a pivotal biomarker in the intricate world of equine physiology. Encoded by the PLGF-1 gene, this glycoprotein is a member of the vascular endothelial growth factor (VEGF) family, boasting a crucial role in angiogenesis—the formation of new blood vessels from pre-existing ones. ePLGF-1 is primarily expressed in endothelial cells, positioning it as a central player in vascular health and regulation.

    The fundamental mission of ePLGF-1 revolves around the orchestration of angiogenesis, a dynamic process that underpins multiple facets of equine life. During embryonic development, ePLGF-1 takes the lead in guiding the creation of an intricate vascular network that ensures the nourishment and oxygenation of the growing equine fetus. This developmental role is nothing short of essential, as it lays the foundation for a healthy and thriving life.

    In adulthood, ePLGF-1 continues to wield its angiogenic powers, particularly in the context of wound healing. When tissue injury occurs, whether due to trauma or surgical intervention, ePLGF-1 steps up to stimulate the growth of new blood vessels at the site of damage. This efficient vascularization accelerates the delivery of nutrients and oxygen to the healing tissue, promoting faster recovery and minimizing the risk of complications.

    Beyond its contributions to embryonic development and wound healing, ePLGF-1 is an indispensable player in the realm of equine reproduction. It ensures proper vascularization of the uterine lining during pregnancy, creating an optimal environment for fetal development. This function underscores the far-reaching influence of ePLGF-1 in shaping the reproductive success of horses.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.